Sai Life Sciences Limited (SAILIFE.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-61.5%

₹602.31

vs ₹1,566.30 price

Levered DCF

₹713.30

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

—

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
P/E	58.36×	85.7×	172.61×	1,593.02×	2,548.83×	216×
P/B	8.2×	6.85×	14.64×	17.91×	18.1×	15.28×
P/S	9.29×	8.6×	9.8×	13.29×	18.3×	17.35×
EV / EBITDA	30.55×	33.54×	48.27×	86.92×	112.12×	82.9×
Gross margin	35.2%	36.5%	33.5%	26.6%	30.7%	67.7%
Operating margin	21.2%	16.1%	12.4%	6.4%	4.1%	37.1%
Net margin	15.9%	10.0%	5.7%	0.8%	0.7%	8.0%
Current ratio	1.69×	2.05×	1.28×	1.27×	1.32×	1.34×
Debt / equity	0.12×	0.17×	0.95×	1.05×	1.1×	0.78×
Interest coverage	11.83×	3.49×	2.11×	1×	0.72×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Return on equity	14.0%	8.0%	8.5%	1.1%	0.7%	7.1%
Return on invested capital	11.8%	7.8%	6.8%	2.5%	1.2%	13.0%
Return on assets	9.6%	5.4%	3.6%	0.5%	0.3%	3.4%
Free cash flow yield	-0.4%	-0.6%	0.6%	0.7%	-0.6%	-2.3%
Earnings yield	1.7%	1.2%	0.6%	0.1%	0.0%	0.5%
Enterprise value	₹205.4B	₹148.4B	₹151.8B	₹167.7B	₹167.5B	₹137.9B
Net debt / EBITDA	0.26×	0.59×	2.87×	4.47×	5.69×	3.65×
Cash conversion cycle (days)	28	111	129	123	164	111